Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1898 (LINC01898) is a member of the long intergenic non-coding RNA (lincRNA) family and is defined as a non-protein coding RNA transcript more than 200 nucleotides in length that does not overlap annotated protein-coding genes. LINC01898, like other lincRNAs, is thought to regulate gene expression by mechanisms including chromatin remodeling, transcriptional regulation, and RNA stabilization, although its specific molecular functions remain poorly characterized. LINC01898 has appeared in panels of long non-coding RNAs used to distinguish cancer tissue from normal tissue in computational classification models, indicating possible dysregulation or biomarker potential in cancer, specifically lung cancer. There is currently no information indicating that LINC01898 serves as a therapeutic target (such as a receptor, enzyme, or transporter), nor are there known direct interacting drugs or established clinical diagnostic assays.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1898 (LINC01898).